[MRNA] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[MRNA] Moderna, Inc.
Announcement Date
23-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 105.98%
YoY- -85.19%
Quarter Report
MRNA's Result
MRNA's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 956,000 2,813,000 5,084,000 6,949,000 229,375 10,553 32,816 75.32%
PBT -1,184,000 70,000 1,655,000 5,410,000 -271,012 -124,409 -141,258 42.47%
Tax -64,000 -147,000 190,000 542,000 1,473 -169 168 -
NP -1,120,000 217,000 1,465,000 4,868,000 -272,485 -124,240 -141,426 41.13%
Tax Rate - 210.00% -11.48% -10.02% - - - -
Total Cost 2,076,000 2,596,000 3,619,000 2,081,000 501,860 134,793 174,242 51.07%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -117.15 7.71 28.82 70.05 -118.79 -1,177.30 -430.97 -19.49%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -2.91 0.57 3.81 12.03 -0.69 -0.37 -0.43 37.49%
EPS Diluted -2.91 0.55 3.62 11.29 -0.69 -0.37 -0.43 37.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.